PPI Coverage Adjusts To Prilosec OTC; Wyeth Sees Growth For Protonix In ‘04

Wyeth expects Protonix (pantoprazole) to remain a readily available "tier 2" agent in most health plans during 2004 despite the changing dynamics in the proton pump inhibitor market